INSP - Inspire Medical Systems, Inc.... | Finranks

05.08.2026

Is INSP a Buy as Margins Improve but Reimbursement Risks Persist?

Inspire Medical's vast sleep apnea opportunity, rising margins and debt-free balance sheet support patience as reimbursement issues weigh on procedures.

05.08.2026

INSP Raises 2026 Outlook as Reimbursement Headwinds Start to Ease

Inspire Medical raised its 2026 outlook after a Q2 beat, as Inspire V mix and cost control offset weak U.S. procedure activity.

05.08.2026

INSP's 28.1% Past-Month Rally Raises a Key Question for Investors

Inspire Medical shares jumped 28.1% as an earnings beat, raised 2026 guidance and estimate revisions offset reimbursement pressure.

04.08.2026

Inspire Medical Q2 Earnings Beat Estimates, '26 View Raised, Stock Up

INSP beats second-quarter estimates, raises its 2026 outlook and sees shares jump despite U.S. reimbursement pressures and lower revenues.

04.08.2026

Inspire Medical Systems Analysts Raise Their Forecasts Following Strong Q2 Results

Inspire Medical Systems Inc (NYSE:INSP) on Monday reported better-than-expected second-quarter financial results and raised its FY26 guidance.

04.08.2026

Inspire Medical Systems, Inc. (INSP) Q2 2026 Earnings Call Transcript

04.08.2026

Inspire Medical Systems Q2 Earnings Call Highlights

Inspire Medical Systems NYSE: INSP reported second-quarter revenue of $200.6 million, down 7.6% from a year earlier, as coding and reimbursement disruptions continued to affect procedure volumes. The company said results exceeded its internal expectations for profitability and cash flow, prompting it to raise its full-year outlook for revenue, adjusted operating margin and adjusted earnings per share.

Видео

No Data

There is no data to display

Повышения / Понижения рейтинга

Тикер	Фирма	Изменение рейтинга	Целевая цена	Дата
INSP	Oppenheimer	Outperform	undefined >> $85	August 4th 2026
INSP	UBS	Sell	undefined >> $39	July 28th 2026

Пресс-релизы

03.08.2026

Inspire Medical Systems, Inc. Announces Second Quarter 2026 Financial Results, Raised 2026 Guidance, and Strategic Growth Plan

Generated second quarter revenue of $200.6 million Second quarter diluted EPS of $0.01; adjusted diluted EPS of $0.14 Second quarter operating cash flow of $23.2 million Announced strategic growth plan designed to unlock and redeploy $30 million for growth initiatives MINNEAPOLIS, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire, or the Company), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today reported financial results for the quarter ended June 30, 2026. “Our second quarter results reflect the increased discipline and focus we are bringing to the business as we continue to support customers through the evolving coding and reimbursement environment and invest in the long-term adoption of Inspire therapy,” said Tim Herbert, Chairman and CEO of Inspire Medical Systems.

Inspire Medical Systems, Inc. (INSP)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Inspire Medical Systems, Inc. (INSP)

Is INSP a Buy as Margins Improve but Reimbursement Risks Persist?

INSP Raises 2026 Outlook as Reimbursement Headwinds Start to Ease

INSP's 28.1% Past-Month Rally Raises a Key Question for Investors

Inspire Medical Q2 Earnings Beat Estimates, '26 View Raised, Stock Up

Inspire Medical Systems Analysts Raise Their Forecasts Following Strong Q2 Results

Inspire Medical Systems, Inc. (INSP) Q2 2026 Earnings Call Transcript

Inspire Medical Systems Q2 Earnings Call Highlights

Видео

No Data

Повышения / Понижения рейтинга

Пресс-релизы

Inspire Medical Systems, Inc. Announces Second Quarter 2026 Financial Results, Raised 2026 Guidance, and Strategic Growth Plan

Search stocks

Inspire Medical Systems, Inc. (INSP)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Inspire Medical Systems, Inc. (INSP)

Is INSP a Buy as Margins Improve but Reimbursement Risks Persist?

INSP Raises 2026 Outlook as Reimbursement Headwinds Start to Ease

INSP's 28.1% Past-Month Rally Raises a Key Question for Investors

Inspire Medical Q2 Earnings Beat Estimates, '26 View Raised, Stock Up

Inspire Medical Systems Analysts Raise Their Forecasts Following Strong Q2 Results

Inspire Medical Systems, Inc. (INSP) Q2 2026 Earnings Call Transcript

Inspire Medical Systems Q2 Earnings Call Highlights

Видео

No Data

Повышения / Понижения рейтинга

Пресс-релизы

Inspire Medical Systems, Inc. Announces Second Quarter 2026 Financial Results, Raised 2026 Guidance, and Strategic Growth Plan